» Articles » PMID: 2472640

Substance P Receptor Binding Sites Are Expressed by Glia in Vivo After Neuronal Injury

Overview
Specialty Science
Date 1989 Jul 1
PMID 2472640
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro studies have demonstrated that glia can express functional receptors for a variety of neurotransmitters. To determine whether similar neurotransmitter receptors are also expressed by glia in vivo, we examined the glial scar in the transected optic nerve of the albino rabbit by quantitative receptor autoradiography. Receptor binding sites for radiolabeled calcitonin gene-related peptide, cholecystokinin, galanin, glutamate, somatostatin, substance P, and vasoactive intestinal peptide were examined. Specific receptor binding sites for each of these neurotransmitters were identified in the rabbit forebrain but were not detected in the normal optic nerve or tract. In the transected optic nerve and tract, only receptor binding sites for substance P were expressed at detectable levels. The density of substance P receptor binding sites observed in this glial scar is among the highest observed in the rabbit forebrain. Ligand displacement and saturation experiments indicate that the substance P receptor binding site expressed by the glial scar has pharmacological characteristics similar to those of substance P receptors in the rabbit striatum, rat brain, and rat and canine gut. The present study demonstrates that glial cells in vivo express high concentrations of substance P receptor binding sites after transection of retinal ganglion cell axons. Because substance P has been shown to regulate inflammatory and immune responses in peripheral tissues, substance P may also, by analogy, be involved in regulating the glial response to injury in the central nervous system.

Citing Articles

Role of substance P in cerebral edema and association with an estimated specific gravity of the brain and an outcome prediction in post-traumatic cerebral edema.

Konar S, Shukla D, Devi B, Christopher R, S N, Puybasset L World Neurosurg X. 2024; 23:100355.

PMID: 38516024 PMC: 10955688. DOI: 10.1016/j.wnsx.2024.100355.


Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.

Dang D, Shin E, Kim D, Tran H, Jeong J, Jang C J Neuroinflammation. 2018; 15(1):52.

PMID: 29467000 PMC: 5822489. DOI: 10.1186/s12974-018-1087-7.


New Prognostic Biomarkers in Patients With Traumatic Brain Injury.

Lorente L Arch Trauma Res. 2016; 4(4):e30165.

PMID: 26848476 PMC: 4733516. DOI: 10.5812/atr.30165.


Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.

Lorente L, Martin M, Almeida T, Hernandez M, Ramos L, Argueso M Crit Care. 2015; 19:192.

PMID: 25928056 PMC: 4424826. DOI: 10.1186/s13054-015-0911-z.


Increased neuronal expression of neurokinin-1 receptor and stimulus-evoked internalization of the receptor in the rostral ventromedial medulla of the rat after peripheral inflammatory injury.

Hamity M, Walder R, Hammond D J Comp Neurol. 2014; 522(13):3037-51.

PMID: 24639151 PMC: 4107186. DOI: 10.1002/cne.23564.


References
1.
Latov N, Nilaver G, Zimmerman E, Johnson W, Silverman A, Defendini R . Fibrillary astrocytes proliferate in response to brain injury: a study combining immunoperoxidase technique for glial fibrillary acidic protein and radioautography of tritiated thymidine. Dev Biol. 1979; 72(2):381-4. DOI: 10.1016/0012-1606(79)90127-1. View

2.
Mantyh P, Gates T, Mantyh C, Maggio J . Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci. 1989; 9(1):258-79. PMC: 6570011. View

3.
Raff M, Abney E, Cohen J, Lindsay R, Noble M . Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci. 1983; 3(6):1289-1300. PMC: 6564607. View

4.
Rougon G, Noble M, Mudge A . Neuropeptides modulate the beta-adrenergic response of purified astrocytes in vitro. Nature. 1983; 305(5936):715-7. DOI: 10.1038/305715a0. View

5.
Evans T, McCarthy K, Harden T . Regulation of cyclic AMP accumulation by peptide hormone receptors in immunocytochemically defined astroglial cells. J Neurochem. 1984; 43(1):131-8. DOI: 10.1111/j.1471-4159.1984.tb06688.x. View